Published August 27, 2026 · updated August 27, 2026

GLP-1 telehealth red flags: 14 signs to walk away

Fourteen warning signs in a GLP-1 telehealth offer, each tied to a specific field we record for every provider, so you can check them on the profile before you pay.

Each flag names the provider-record field that would show it, so the check takes seconds on the provider profile.

No prescription, no questionnaire, no clinician. A GLP-1 medication is prescription-only. A site that ships without a prescriber review is not a telehealth provider. Field: clinical model; a provider with no prescriber types and no intake is not listed here at all.
“FDA-approved compounded”. No compounded drug is FDA-approved. The phrase is a misstatement of the product’s status. Field: disclosures (compounded-not-approved statement).
The pharmacy is a secret. A provider that will not name the pharmacy prevents you from checking its licence or inspection history. Field: pharmacies (named / not named).
The headline price is a first-month price and the next month’s price is not stated. Field: intro (introductory amount, duration, then-amount). The Introductory vs Recurring study counts how common this is.
A required fee with no amount. “Plus consultation fee” or “membership required” without a number means the true cost cannot be known before you commit. Field: cost components with status not-published.
The price at higher doses is not published. Most patients titrate upward; a plan that publishes only the starting-dose price hides the cost of months four to twelve. Field: dose pricing (dose-stable / dose-tiered / not confirmed).
“Cancel anytime” next to a term. A twelve-month term with a notice period is not “anytime”. Field: commitment type and cancellation notice days.
Cancellation by phone only, during business hours. Field: consumer protections (self-serve cancellation).
Terms of service only after payment. Field: consumer protections (terms before checkout).
Promises of specific weight loss. “Lose 20 lb in 8 weeks” is a marketing claim no trial supports for an individual; the labels describe trial averages with wide ranges. Field: none; it is a content flag recorded in the profile notes.
Testimonials with no disclosure. Endorsements must disclose material connections under the FTC’s Endorsement Guides. Field: profile notes.
Additives sold as benefits. Vitamin B12, glycine, niacinamide or L-carnitine in a compounded vial change the formulation; there is no trial showing they improve outcomes. A provider that presents them as clinical advantages is overstating the evidence. Field: additives; formulation evidence disclosure.
No state licence check. The prescriber must be licensed in your state. A provider that does not ask where you are located, or that serves states where its pharmacy is not licensed, is a flag. Field: states served.
A price found only on another comparison site. If a provider’s own page and checkout do not show the price a review site quotes, treat the review site’s figure as unverified. On this site, that situation is labelled supplied, not yet verified, and the figure is excluded from every ranking.

If you see two or more of these, the questions to ask before paying will usually resolve whether the provider is worth continuing with.

Sources

Provider records and verification statuses in the pricing database (provider)
FDA: FDA's concerns with unapproved GLP-1 drugs used for weight loss (regulator)
FTC: Endorsement Guides (16 CFR Part 255) (regulator)

Compounded medications are not FDA-approved. Report an error.